Gsa Capital Partners LLP Intellia Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

$1.43 Billion
Q2 2025

A detailed history of Gsa Capital Partners LLP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 184,383 shares of NTLA stock, worth $2.51 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

184,383

Previous 219,918 16.16%

Holding current value

$2.51 Million

Previous $1.56 Million 10.61%

% of portfolio

0.12%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	SELL	$6.28 - $9.67 $223,159 - $343,623	-35,535 Reduced 16.16%	184,383 $1.73 Million
Q1 2025 May 08, 2025	BUY	$7.11 - $12.8 $949,732 - $1.71 Million	133,577 Added 154.71%	219,918 $1.56 Million
Q4 2024 Feb 07, 2025	BUY	$11.41 - $21.09 $985,150 - $1.82 Million	86,341 New	86,341 $1.01 Million
Q2 2024 Aug 15, 2024	BUY	$20.02 - $27.22 $1.41 Million - $1.92 Million	70,355 New	70,355 $1.58 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $131,113 - $247,500	3,948 Added 37.94%	14,355 $501,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $561,145 - $746,181	10,407 New	10,407 $582,000
Q1 2020 May 12, 2020	SELL	$9.44 - $15.58 $316,551 - $522,444	-33,533 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$10.43 - $17.67 $349,749 - $592,528	33,533 New	33,533 $492,000
Q3 2019 Nov 12, 2019	SELL	$13.07 - $18.51 $399,353 - $565,573	-30,555 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$13.88 - $18.41 $280,112 - $371,532	20,181 Added 194.53%	30,555 $500,000
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $132,683 - $182,789	10,374 New	10,374 $177,000
Q2 2018 Aug 09, 2018	SELL	$20.02 - $30.79 $1.04 Million - $1.6 Million	-51,900 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$19.43 - $34.95 $1.01 Million - $1.81 Million	51,900 New	51,900 $1.1 Million
Q4 2017 Feb 14, 2018	SELL	$17.39 - $31.12 $1.27 Million - $2.27 Million	-73,100 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$15.16 - $25.75 $1.11 Million - $1.88 Million	73,100	73,100 $1.82 Million

Others Institutions Holding NTLA

# of Institutions

337

Shares Held

98.3M

Call Options Held

784K

Put Options Held

713K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.03B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Intellia Therapeutics, Inc. Transaction History